Akihiko Fujie

1.2k total citations
45 papers, 960 citations indexed

About

Akihiko Fujie is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, Akihiko Fujie has authored 45 papers receiving a total of 960 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pharmacology, 19 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in Akihiko Fujie's work include Microbial Natural Products and Biosynthesis (24 papers), Fungal Biology and Applications (13 papers) and Antifungal resistance and susceptibility (9 papers). Akihiko Fujie is often cited by papers focused on Microbial Natural Products and Biosynthesis (24 papers), Fungal Biology and Applications (13 papers) and Antifungal resistance and susceptibility (9 papers). Akihiko Fujie collaborates with scholars based in Japan, United States and Malaysia. Akihiko Fujie's co-authors include YASUHISA TSURUMI, TOSHIRO IWAMOTO, MASAKUNI OKUHARA, Hideyuki Muramatsu, Seiji Hashimoto, Motohiro Hino, Michizane Hashimoto, MASANOBU KOHSAKA, Shigehiro Takase and Mayumi Ohnishi‐Kameyama and has published in prestigious journals such as Nature Biotechnology, Antimicrobial Agents and Chemotherapy and Tetrahedron Letters.

In The Last Decade

Akihiko Fujie

45 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akihiko Fujie Japan 16 482 471 230 187 159 45 960
Philipp Krastel Switzerland 19 511 1.1× 645 1.4× 141 0.6× 235 1.3× 147 0.9× 32 1.1k
Carl J. Balibar United States 18 604 1.3× 689 1.5× 180 0.8× 125 0.7× 219 1.4× 27 1.2k
Azusa Takahashi‐Nakaguchi Japan 23 245 0.5× 348 0.7× 404 1.8× 158 0.8× 209 1.3× 63 1.1k
Nobuhiro Koyama Japan 17 318 0.7× 366 0.8× 114 0.5× 102 0.5× 126 0.8× 37 791
Junji Inokoshi Japan 25 589 1.2× 795 1.7× 100 0.4× 332 1.8× 312 2.0× 48 1.4k
Maria Cândida Monteiro Spain 16 225 0.5× 242 0.5× 313 1.4× 88 0.5× 98 0.6× 20 765
Deming Xu Canada 19 250 0.5× 723 1.5× 405 1.8× 133 0.7× 63 0.4× 30 1.3k
Hideaki Ui Japan 20 362 0.8× 552 1.2× 58 0.3× 295 1.6× 131 0.8× 36 1.1k
Xu‐Ming Mao China 22 788 1.6× 824 1.7× 138 0.6× 191 1.0× 293 1.8× 67 1.3k
Jianlan You United States 16 267 0.6× 326 0.7× 112 0.5× 86 0.5× 132 0.8× 23 833

Countries citing papers authored by Akihiko Fujie

Since Specialization
Citations

This map shows the geographic impact of Akihiko Fujie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akihiko Fujie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akihiko Fujie more than expected).

Fields of papers citing papers by Akihiko Fujie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akihiko Fujie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akihiko Fujie. The network helps show where Akihiko Fujie may publish in the future.

Co-authorship network of co-authors of Akihiko Fujie

This figure shows the co-authorship network connecting the top 25 collaborators of Akihiko Fujie. A scholar is included among the top collaborators of Akihiko Fujie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akihiko Fujie. Akihiko Fujie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Motoo, et al.. (2020). Cloning and heterologous expression of P450Lent4B11, a novel bacterial P450 gene, for hydroxylation of an antifungal agent sordaricin. The Journal of Antibiotics. 73(9). 615–621. 1 indexed citations
2.
Watanabe, Masato, et al.. (2014). Therapeutic efficacy of AS2077715 against experimental tinea pedis in guinea pigs in comparison with terbinafine. The Journal of Antibiotics. 67(10). 717–719. 1 indexed citations
3.
Takase, Shigehiro, et al.. (2014). AS2077715: a novel antifungal antibiotic produced by Capnodium sp. 339855. The Journal of Antibiotics. 67(10). 707–711. 5 indexed citations
4.
Yamashita, M., Shigehiro Takase, Michizane Hashimoto, et al.. (2013). Identification of ten KB425796-A congeners from Paenibacillus sp. 530603 using an antifungal assay against Aspergillus fumigatus in combination with micafungin. The Journal of Antibiotics. 66(8). 473–478. 2 indexed citations
5.
Yamashita, M., Shigehiro Takase, Michizane Hashimoto, et al.. (2013). KB425796-A, a novel antifungal antibiotic produced by Paenibacillus sp. 530603. The Journal of Antibiotics. 66(8). 465–471. 8 indexed citations
6.
Takase, Shigehiro, Toshiko Yamada, Hideyuki Muramatsu, et al.. (2010). Bioconversion of AS1387392: bioconversion studies involving Amycolatopsis azurea JCM 3275. The Journal of Antibiotics. 63(11). 643–647. 7 indexed citations
7.
Muramatsu, Hideyuki, Shigehiro Takase, Akihiko Fujie, et al.. (2010). Bioconversion of AS1387392: screening and characterization of actinomycetes that convert AS1387392 to AS1429716. The Journal of Antibiotics. 63(11). 637–642. 11 indexed citations
8.
Yamashita, M., et al.. (2010). Cloning and heterologous expression of P450Um-1, a novel bacterial P450 gene, for hydroxylation of immunosuppressive agent AS1387392. The Journal of Antibiotics. 63(11). 649–656. 9 indexed citations
9.
Sato, Ikuko, N. Yamamoto, Susan R. Rittling, et al.. (2008). Osteopontin is dispensable for protection against high load systemic fungal infection. International Immunopharmacology. 8(10). 1441–1448. 4 indexed citations
10.
Fujie, Akihiko. (2007). Discovery of micafungin (FK463): A novel antifungal drug derived from a natural product lead. Pure and Applied Chemistry. 79(4). 603–614. 25 indexed citations
11.
Sakamoto, Kazutoshi, Michizane Hashimoto, Shigehiro Takase, et al.. (2006). FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738. The Journal of Antibiotics. 59(3). 137–144. 20 indexed citations
12.
Kobayashi, Motoo, Seiji Yoshimura, Takayoshi Kinoshita, et al.. (2005). FR207944, an Antifungal Antibiotic fromChaetomiumsp. No. 217 II. Isolation and Structure Elucidation. Bioscience Biotechnology and Biochemistry. 69(5). 1029–1032. 7 indexed citations
13.
Fujie, Akihiko, TOSHIRO IWAMOTO, Bunji Sato, et al.. (2001). FR131535, a novel water-soluble echinocandin-like lipopeptide: synthesis and biological properties. Bioorganic & Medicinal Chemistry Letters. 11(3). 399–402. 16 indexed citations
14.
Fujie, Akihiko, TOSHIRO IWAMOTO, Hideyuki Muramatsu, et al.. (2000). FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243. I. Taxonomy, Fermentation, Isolation, Physico-chemical Properties and Biological Properties.. The Journal of Antibiotics. 53(9). 912–919. 44 indexed citations
15.
Fujie, Akihiko, TOSHIRO IWAMOTO, Hideyuki Muramatsu, et al.. (2000). FR901469, a Novel Antifungal Antibiotic from an Unidentified Fungus No. 11243. II. In Vitro and In Vivo Activities.. The Journal of Antibiotics. 53(9). 920–927. 28 indexed citations
16.
Furuta, Takahisa, et al.. (1997). Therapeutic Effect of a Water‐Soluble Echinocandian Compound on Pneumocystis Pneumonia in Animals. Journal of Eukaryotic Microbiology. 44(s6). 53S–53S. 3 indexed citations
17.
IWAMOTO, TOSHIRO, et al.. (1994). WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties.. The Journal of Antibiotics. 47(10). 1092–1097. 48 indexed citations
18.
Fujie, Akihiko, TOSHIRO IWAMOTO, Nobuharu Shigematsu, et al.. (1990). FR112123, a new oligopeptide antibiotic from Streptomyces viridochromogenes. Taxonomy, fermentation, isolation, physico-chemical properties, structure and biological activity.. The Journal of Antibiotics. 43(5). 449–455. 1 indexed citations
19.
Hashimoto, Seiji, et al.. (1990). Studies on new dehydropeptidase inhibitors. III. Biological properties of WS1358A1.. The Journal of Antibiotics. 43(3). 281–285. 1 indexed citations
20.
Ando, Takeshi, Satoshi Okada, Itsuo Uchida, et al.. (1987). WF-10129, a novel angiotensin converting enzyme inhibitor produced by a fungus, Doratomyces putredinis.. The Journal of Antibiotics. 40(4). 468–475. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philipp Krastel Breakdown of academic impact, for papers by Carl J. Balibar Breakdown of academic impact, for papers by Azusa Takahashi‐Nakaguchi Breakdown of academic impact, for papers by Nobuhiro Koyama Breakdown of academic impact, for papers by Junji Inokoshi Breakdown of academic impact, for papers by Maria Cândida Monteiro Breakdown of academic impact, for papers by Deming Xu Breakdown of academic impact, for papers by Hideaki Ui Breakdown of academic impact, for papers by Xu‐Ming Mao Breakdown of academic impact, for papers by Jianlan You
Rankless by CCL
2026